PYPD MEXC RealStocks
Own real PYPD shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 07:02:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
PolyPid Ltd. (PYPD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $6.53, with a market capitalization of $138.16M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.50 to $7.15. This page covers its latest market performance, valuation, price trends and company information.
$138.16M | |
$6.60 | |
$6.80 | |
$6.48 | |
$6.54 | |
295.74K | |
139.08K | |
-- | |
$7.15 | |
$3.50 | |
-- | |
2026-06-30 |
PolyPid Ltd. (PYPD) last closed at $6.53 as of 2026-11-19 00:51:00, up 0.38% ($0.03) from the previous close of $6.54.
During the latest regular trading session, PYPD traded between $6.48 and $6.80, with a volume of 295.74K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, PolyPid Ltd. (PYPD) moved from $6.31 to $6.53, representing a gain of 3.52% ($0.22).
The stock traded between $5.90 and $7.15 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 322.74 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 83.1%
PYPD is currently trading at $6.53, placing it 83.1% of the way from its 52-week low of $3.50 to its 52-week high of $7.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
| Employees | 75 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of PolyPid Ltd. (PYPD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PYPD, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between PYPD shares and USD.
PYPD Shares to USD
1.00 PYPD shares = 6.532 USD
Calculations are estimates based on the latest available price and are for reference only.